PharmStock Pharmacy Stock

Finpecia
Finpecia

0.76
A generic medicine indicated for prostate conditions. Targets enzyme activity to lower dihydrotestosterone levels and address prostate enlargement symptoms.
Ingredient
Finasteride
Category
Prostate Health
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Finasteride
Reference Brand
Finasteride
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
5-Alpha Reductase Inhibitor
Pharmacological Class
Androgen Synthesis Inhibitor
Clinical Indications
Benign prostatic hyperplasia
Manufacturer Description
Formulated to alleviate prostate enlargement to support urinary stream flow and target hormonal conversion pathways.
Mechanism of Action
Inhibits type II 5-alpha reductase, blocking the conversion of testosterone to dihydrotestosterone to reduce prostate tissue volume.
Route of Administration
Oral
Onset Time
3–6 months
Duration
24 hours
Contraindications
Pregnancy, Hypersensitivity to finasteride
Severe Adverse Events
Allergic angioedema — requires immediate medical attention
Common Side Effects
Decreased libido, Erectile dysfunction
Uncommon Side Effects
Ejaculation disorder, Breast tenderness, Depression
Pregnancy Safety Warnings
TGA Category X: Highly teratogenic to male fetuses. Pregnant women must not handle crushed tablets. Breastfeeding: Not applicable.
Age Restrictions
Approved for adult males.
Storage Guidelines
Store below 25°C.
Related Products
Propecia, Avodart
Information related to Finpecia is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Diabetes Management AU - Forxiga Price